Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
Retrospective Observational Study With Real-World Data to Assess Demographic and Clinicopathological Profiles, and Management of Breast Cancer Patients With Positive, Low or Negative Expression of HER2 in Spain (RosHER)

This is a data-driven, retrospective, longitudinal, population- based, observational, multi-centered study using secondary data captured from congruent electronic health records (EHRs).

  • 0 views
  • 25 Oct, 2022
  • 5 locations
Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

Breast cancer is a major cause of survival for women worldwide. Neoadjuvant therapy as an important treatment for locally advanced breast cancer has had many positive effects for breast cancer

invasive breast cancer
locally advanced breast cancer
advanced breast cancer
  • 0 views
  • 04 Oct, 2022
  • 1 location
Pilot Investigation of Ultrasound Imaging and Spectroscopy as Early Indicators of Locally- Advanced Breast Cancer Response to Neoadjuvant Treatment

This work explores the possibility of using ultrasound imaging and spectroscopy as a way of monitoring cell death, hence, tumour response to treatment. The hypothesis here is that it can be used as a way of monitoring early response to cancer treatment and predicting which patients continue on in their …

carcinoma
adjuvant therapy
cancer treatment
measurable disease
breast carcinoma
  • 0 views
  • 15 Oct, 2022
  • 1 location
A Pilot Study To Evaluate the Effectiveness of Pulsed Time-Domain Optical Spectroscopy for Monitoring the Responses in Neoadjuvant Treatments of Locally-Advanced Breast Cancer

complete response in women with locally advanced breast cancer receiving treatment with neoadjuvant treatments such as chemotherapy or neoadjuvant combined modality chemotherapy and radiotherapy.

adjuvant therapy
cancer treatment
locally advanced breast cancer
breast cancer, treatment
advanced breast cancer
  • 11 views
  • 24 Oct, 2022
  • 1 location
SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY (NEOSENTITURK)

study, the investigators evaluated factors affecting local recurrence and outcome in patients with locally advanced breast cancer (LABC), who underwent sentinel lymph node (SLN) with or without ALND

Accepts healthy volunteers
  • 0 views
  • 25 Feb, 2022
  • 1 location
Palbociclib Combinations in HR+/HER2- Metastatic Breast Cancer Patients: A Non-Interventional Prospective Study on the Treatment Patterns & Clinical Outcomes in Africa Middle East (PRECIOUS) (PRECIOUS)

knowledge of HR+ HER2-metastatic/locally advanced Breast Cancer (BC) disease management, its treatment pattern, clinical outcomes and quality of life (QoL) in the routine clinical practice in Africa and

  • 0 views
  • 12 Oct, 2022
  • 2 locations
MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

neoadjuvant chemotherapy given to patients with locally advanced breast cancer, thus allowing early chemotherapy regimen modification to increase number of patients achieving pathological complete response or

locally advanced breast cancer
carcinoma
breast carcinoma
advanced breast cancer
  • 0 views
  • 04 Oct, 2022
  • 1 location
Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients With Symp-tomatic Visceral Metastases or High Tumor Burden (Abemacare)

Breast cancer is one of the most common cancers in women. 20-30 % of all breast cancer patients are faced with advanced disease, comprising both locally advanced breast cancer (LABC) and

  • 0 views
  • 14 May, 2022
  • 1 location
Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant Therapy

soluble immune checkpoints in predicting the response to neoadjuvant therapy in locally advanced breast cancers.

tumor cells
locally advanced breast cancer
advanced breast cancer
  • 0 views
  • 07 Oct, 2022
  • 1 location
An EORTC Study Updating the QLQ-BR23 to BR45

subgroup of patients from the local/ locally advanced breast cancer group (who have had change in disease or treatment status after the first assessment) will be invited to complete a second set of

female breast cancer
breast cancer
primary cancer
metastasis
advanced breast cancer
  • 0 views
  • 06 Jun, 2022
  • 1 location